Clinical trials
Recruiting Observational Ureteral Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yonsei University | 2 |
| Guardant Health, Inc. | 1 |
| Peking University First Hospital | 1 |
| University of Nebraska | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ureteral Neoplasms | 5 |
| Urinary Bladder Neoplasms | 4 |
| Carcinoma, Renal Cell | 3 |
| Prostatic Neoplasms | 3 |
| Colonic Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Melanoma | 2 |
| Rectal Neoplasms | 2 |
| Adenomatous Polyposis Coli | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.